Corvus Pharmaceuticals (CRVS) Accumulated Depreciation & Amortization (2022 - 2025)
Historic Accumulated Depreciation & Amortization for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to $28000.0.
- Corvus Pharmaceuticals' Accumulated Depreciation & Amortization rose 4000.0% to $28000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $28000.0, marking a year-over-year increase of 4000.0%. This contributed to the annual value of $100000.0 for FY2024, which is 5000.0% down from last year.
- According to the latest figures from Q3 2025, Corvus Pharmaceuticals' Accumulated Depreciation & Amortization is $28000.0, which was up 4000.0% from $29000.0 recorded in Q2 2025.
- In the past 5 years, Corvus Pharmaceuticals' Accumulated Depreciation & Amortization registered a high of $4.3 million during Q1 2022, and its lowest value of $20000.0 during Q3 2024.
- Over the past 4 years, Corvus Pharmaceuticals' median Accumulated Depreciation & Amortization value was $36000.0 (recorded in 2023), while the average stood at $366066.7.
- As far as peak fluctuations go, Corvus Pharmaceuticals' Accumulated Depreciation & Amortization crashed by 9868.63% in 2023, and later soared by 4000.0% in 2025.
- Over the past 4 years, Corvus Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $400000.0 in 2022, then tumbled by 50.0% to $200000.0 in 2023, then tumbled by 50.0% to $100000.0 in 2024, then tumbled by 72.0% to $28000.0 in 2025.
- Its Accumulated Depreciation & Amortization stands at $28000.0 for Q3 2025, versus $29000.0 for Q2 2025 and $22000.0 for Q1 2025.